MedTrace Logo

Vitamin D Supplementation for Treatment of Dyslipidemia

NCT03133975 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-08-21

No results posted yet for this study

Summary

This study will be conducted to Assess possible reduction in lipid profile (LDL-Triglecerides-cholesterol) among pre-menopausal women in vit D group compared to standard treatment group after 3 months \& 6 month of follow up as prophylaxis step for atherosclerosis.

Conditions

  • Dyslipidemias

Interventions

DRUG

Vitamin D3 (Treatment)

Single high dose vitamin D3 in treatment of dyslipedemia

OTHER

Mixed diet of carbohydrate and protein (Control)

Mixed diet of carbohydrate and protein

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Nibal Murad, lectURER · Mansoura University-Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-12-31
Completion
2019-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03133975 on ClinicalTrials.gov